// App-Quantinova.ai

3288 : The chemokine receptor CXCR4 and the cannabinoid receptor CB2R form heterodimers in non-Hodgkin lymphoma (NHL) and solid tumors leading to functional crosstalk

Researchers

Presenter

  • Martina Guerrero

Principal Investigators

  • Rosa Griera

  • Maria Perez

  • Gael Roue

  • Joan Bosch

  • Peter J. McCormick

  • Jordi Camps

  • Patricia Perez-Galan

Medical Centers

  • IDIBAPS, Badalona, Spain

  • Universitat de Barcelona, Barcelona, Spain

  • The University of East Anglia, Norwich, United Kingdom

Locations

  • Spain

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non-Hodgkin's Lymphoma

  • Breast cancer

  • Solid malignancies

  • Non‐Hodgkin Lymphoma

  • Lymphomas

Biomarkers

  • C-X-C motif chemokine receptor 4

  • erb-b2 receptor tyrosine kinase 2

  • Cannabinoid receptor type I

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved